The Colentina doctors’ study has attracted the attention of the Scientific Senate of the Dan Voiculescu Foundation for the Development of Romania, which is committed to supporting excellence in medicine and is interested in providing continued support for the study.
The head of internal medicine II, Professor Dr. Cristian Băicuș, spoke to Antena 3 about the results of the study.
“It was the idea of my pulmonologist colleague who called me and told me that he thought thrombosis was too important and looked for causes. We recruited 91 patients and showed that protein S is low in these patients. We are trying to recall as many of the 91 as we can to re-dose them with protein S. About 20 have died so we have no way to recall them,” the doctor explained.
“So far we have been able to prove that the more severe the symptoms, the lower the protein, the question is whether it decreases because of the infection or the other way around, maybe that’s why the thrombosis occurs. This is what we want to point out. Not having a basal level, we will try to convince them to come to the hospital to re-dose their protein, if it is normal it means it was low due to the disease, if it is still low it means the protein S was congenitally low and we can know which patients are at higher risk
I’ve had covid too, minimal simtpomatic. I had the usual cold. My antibodies dropped after about 3-4 months”, Cristian Băicuș, head of internal medicine II, told Antena 3.